127 related articles for article (PubMed ID: 6588671)
1. Phase II evaluation of 4'epi-doxorubicin in patients with metastatic colorectal carcinoma.
Ferrazzi E; Pappagallo GL; Nicoletto O; Fornasiero A; Refatti F; Cartei G; Vinante O; Fiorentino MV
Tumori; 1984 Jun; 70(3):297-300. PubMed ID: 6588671
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of 4'epi-doxorubicin.
Ferrazzi E; Nicoletto O; Vinante O; Pagnin P; Maraglino G; Ganzina F; Fiorentino MV
Tumori; 1982 Oct; 68(5):431-5. PubMed ID: 6960591
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of 4'-epi-doxorubicin in metastatic colorectal carcinoma.
Wils JA
Invest New Drugs; 1984; 2(4):397-9. PubMed ID: 6595243
[TBL] [Abstract][Full Text] [Related]
4. Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC).
Holdener EE; Hansen HH; Høst H; Bruntsch U; Cavalli F; Renard J; Pinedo HM; Rozencweig M
Invest New Drugs; 1985; 3(1):63-6. PubMed ID: 3857219
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of 4'epi-adriamycin for advanced hypernephroma.
Benedetto P; Ahmed T; Needles B; Watson RC; Yagoda A
Am J Clin Oncol; 1983 Oct; 6(5):553-4. PubMed ID: 6577784
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of esorubicin in patients with advanced colorectal carcinoma.
Fiore J; Kemeny N; Raymond V; Young C
Cancer Treat Rep; 1986 Oct; 70(10):1241-2. PubMed ID: 3530453
[No Abstract] [Full Text] [Related]
7. Phase II evaluation of 4'-epi-doxorubicin in patients with metastatic colorectal carcinoma.
Ajani JA; Kanojia MD; Bodey GP
Cancer Treat Rep; 1984 Dec; 68(12):1507-8. PubMed ID: 6595058
[No Abstract] [Full Text] [Related]
8. Phase II trial of 4'-epi-doxorubicin in advanced colorectal carcinoma: a Northern California Oncology Group study.
Meyers FJ; Lewis B; Mitchell E; William L; Hannigan JF; Gribble M; Torti FM
Cancer Treat Rep; 1985 Jan; 69(1):143-4. PubMed ID: 3855385
[No Abstract] [Full Text] [Related]
9. Phase II evaluation of 4'-epi-doxorubicin in patients with advanced colorectal carcinoma.
Michaelson R; Kemeny N; Young C
Cancer Treat Rep; 1982 Sep; 66(9):1757-8. PubMed ID: 6956441
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of alanosine in advanced large bowel carcinoma.
Rubin J; Hineman V; Moertel CG; Schutt AJ; Hahn RG
Am J Clin Oncol; 1983 Apr; 6(2):191-3. PubMed ID: 6829493
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of acivicin in patients with advanced colorectal carcinoma.
Adolphson CC; Ajani JA; Stroehlein JR; Barlogie B; Bodey GP; Korinek J; Bedikian AY
Am J Clin Oncol; 1986 Jun; 9(3):189-91. PubMed ID: 3728371
[TBL] [Abstract][Full Text] [Related]
12. Phase II evaluation of aclacinomycin A (ACM-A, NSC208734) in patients with metastatic colorectal cancer.
Bedikian AY; Stroehlein J; Korinek J; Karlin D; Valdivieso M; Bodey G
Am J Clin Oncol; 1983 Apr; 6(2):187-90. PubMed ID: 6572470
[TBL] [Abstract][Full Text] [Related]
13. Phase II clinical evaluation of 4'-epi-doxorubicin.
Hurteloup P; Cappelaere P; Armand JP; Mathé G
Cancer Treat Rep; 1983 Apr; 67(4):337-41. PubMed ID: 6573956
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of 9-10 anthracene-dicarboxaldehyde bis(4,5-dihydro-1H-imidazol-2-yl) hydrazone dihydrochloride (CL216,942; ADAH) in patients with advanced colorectal carcinoma.
Rubin J; Kvols LK; Moertel CG; Jones AR; Hahn RG; O'Connell MJ
Am J Clin Oncol; 1983 Aug; 6(4):477-9. PubMed ID: 6869319
[TBL] [Abstract][Full Text] [Related]
15. Phase II evaluation of pyrazofurin in patients with advanced colorectal carcinoma.
Carroll DS; Kemeny NE; Gralla RJ
Cancer Treat Rep; 1979 Jan; 63(1):139-40. PubMed ID: 369686
[No Abstract] [Full Text] [Related]
16. Phase II study of a 21-day continuous infusion schedule with epirubicin in metastatic colorectal cancer.
Greidanus J; Willemse PH; Sleijfer DT; Mulder NH; Verschueren RC; Nieweg R; de Vries EG
Eur J Cancer Clin Oncol; 1988 Apr; 24(4):801-2. PubMed ID: 3164271
[No Abstract] [Full Text] [Related]
17. Phase-II clinical trial of 4'-epi-doxorubicin in metastatic solid tumors.
Kolarić K; Potrebica V; Cervek J
J Cancer Res Clin Oncol; 1983; 106(2):148-52. PubMed ID: 6579052
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of acivicin in colorectal carcinoma: a National Cancer Institute of Canada study.
Maroun JA; Fields AL; Pater JL; Stewart DJ; Cripps C; Eisenhauer E
Cancer Treat Rep; 1984 Sep; 68(9):1121-3. PubMed ID: 6478451
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of 4'-deoxydoxorubicin in advanced colorectal cancer.
Falkson G; Vorobiof DA
Invest New Drugs; 1986; 4(2):165-9. PubMed ID: 3733376
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and central haemodynamic effects of doxorubicin and 4'epi-doxorubicin in the pig.
Andersson M; Domellöf L; Eksborg S; Häggmark S; Johansson G; Reiz S; Herslöf A
Acta Oncol; 1989; 28(5):709-14. PubMed ID: 2590548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
